The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
In this study of 80 people -- from a @nature journal -- the RES group (400 mg/kg/day) after 6 months showed cardiac improvements https://t.co/6y4QSjB1Pw These included smaller left atrial, lower E/e’, higher left ventricular global longitudinal strain & biomarkers indicating cardiac fibrosis (lower procollagen type I C-peptide & galectin-3), compared to the untreated group & consistent with rodent studies (e.g. below) https://t.co/fSC3Ah00mD
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.